Search Page

1

Cite

Share

A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study.

Ziemssen T, Piani-Meier D, Bennett B, Johnson C, Tinsley K, Trigg A, Hach T, Dahlke F, Tomic D, Tolley C, Freedman MS. Ziemssen T, et al. Among authors: hach t. J Med Internet Res. 2020 Feb 12;22(2):e16932. doi: 10.2196/16932. J Med Internet Res. 2020. PMID: 32049062 Free PMC article.

Cite

Share

2

Cite

Share

Improvement of long-term risks of cardiovascular events associated with community-based disease management in Chinese patients of the Xinjiang autonomous region of China.

Li Y, Minzhang C, Minghui M, Xinmiao H, Laixin L, Bei W, Weihai Z, Wei Z, Yumei G, Kongnakorn T, Xiao Y, Peng S, Hughes D, Dashdorj N, Hach T. Li Y, et al. Among authors: hach t. BMC Public Health. 2020 Jun 29;20(1):1034. doi: 10.1186/s12889-020-09157-8. BMC Public Health. 2020. PMID: 32600440 Free PMC article.

Cite

Share

3

Cite

Share

Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition.

Ferrannini G, Hach T, Crowe S, Sanghvi A, Hall KD, Ferrannini E. Ferrannini G, et al. Among authors: hach t. Diabetes Care. 2015 Sep;38(9):1730-5. doi: 10.2337/dc15-0355. Epub 2015 Jul 15. Diabetes Care. 2015. PMID: 26180105 Free PMC article.

Cite

Share

4

Cite

Share

Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK.

Gelhorn HL, Stringer SM, Brooks A, Thompson C, Monz BU, Boye KS, Hach T, Lund SS, Palencia R. Gelhorn HL, et al. Among authors: hach t. Diabetes Obes Metab. 2013 Sep;15(9):802-9. doi: 10.1111/dom.12091. Epub 2013 Apr 7. Diabetes Obes Metab. 2013. PMID: 23464623

Cite

Share

5

Cite

Share

Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration.

Skrtić M, Yang GK, Perkins BA, Soleymanlou N, Lytvyn Y, von Eynatten M, Woerle HJ, Johansen OE, Broedl UC, Hach T, Silverman M, Cherney DZ. Skrtić M, et al. Among authors: hach t. Diabetologia. 2014 Dec;57(12):2599-602. doi: 10.1007/s00125-014-3396-4. Epub 2014 Oct 4. Diabetologia. 2014. PMID: 25280671 No abstract available.

Cite

Share

6

Cite

Share

Treatment satisfaction in type 2 diabetes patients taking empagliflozin compared with patients taking glimepiride.

Chirila C, Zheng Q, Davenport E, Kaschinski D, Pfarr E, Hach T, Palencia R. Chirila C, et al. Among authors: hach t. Qual Life Res. 2016 May;25(5):1199-207. doi: 10.1007/s11136-015-1140-2. Epub 2015 Sep 30. Qual Life Res. 2016. PMID: 26424170 Free PMC article.

Cite

Share

7

Cite

Share

Slope of change in HbA_1c from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes.

DeFronzo RA, Ferrannini E, Schernthaner G, Hantel S, Elsasser U, Lee C, Hach T, Lund SS. DeFronzo RA, et al. Among authors: hach t. Endocrinol Diabetes Metab. 2018 Apr 6;1(2):e00016. doi: 10.1002/edm2.16. eCollection 2018 Apr. Endocrinol Diabetes Metab. 2018. PMID: 30815552 Free PMC article.

Cite

Share

8

Cite

Share

Efficacy and safety of empagliflozin in patients with type 2 diabetes from Asian countries: pooled data from four phase III trials.

Yoon KH, Nishimura R, Lee J, Crowe S, Salsali A, Hach T, Woerle HJ. Yoon KH, et al. Among authors: hach t. Diabetes Obes Metab. 2016 Oct;18(10):1045-9. doi: 10.1111/dom.12699. Epub 2016 Jul 13. Diabetes Obes Metab. 2016. PMID: 27265507 Clinical Trial.

Cite

Share

9

Cite

Share

C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.

Hach T, Forst T, Kunt T, Ekberg K, Pfützner A, Wahren J. Hach T, et al. Exp Diabetes Res. 2008;2008:730594. doi: 10.1155/2008/730594. Exp Diabetes Res. 2008. PMID: 18483566 Free PMC article.

Cite

Share

10

Cite

Share

Erratum to: Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration.

Škrtić M, Yang GK, Perkins BA, Soleymanlou N, Lytvyn Y, von Eynatten M, Woerle HJ, Johansen OE, Broedl UC, Hach T, Silverman M, Cherney DZI. Škrtić M, et al. Among authors: hach t. Diabetologia. 2017 Jun;60(6):1159-1160. doi: 10.1007/s00125-017-4241-3. Diabetologia. 2017. PMID: 28374067 No abstract available.

Cite

Share